Cited by 3,125Heart Failure Treatment and ManagementElectrolyte and hormonal disordersCardiac Fibrosis and Remodeling

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Cohn, Jay N., Levine, T. Barry, Olivari, Maria Teresa, Garberg, Victoria, Lura, Dennis, Francis, Gary S., Simon, Ada B., Rector, Thomas·1984·New England Journal of Medicine

DOI 10.1056/nejm198409273111303

Open this paper in CoChat — free account

Abstract

Hemodynamics, plasma norepinephrine, and plasma renin activity were measured at supine rest in 106 patients (83 men and 23 women) with moderate to severe congestive heart failure. During follow-up lasting 1 to 62 months, 60 patients died (57 per cent); 47 per cent of the deaths were sudden, and 45 per cent were related to progressive heart failure. Statistically unrelated to the risk of mortality were cause of disease (60 patients had coronary disease, and 46 had cardiomyopathy), age (mean, 54.8 years), cardiac index (mean, 2.11 liters per minute per square meter of body-surface area), pulmonary wedge pressure (mean, 24.5 mm Hg), and mean arterial pressure (mean, 83.2 mm Hg). A multivariate analysis of the five significant univariate prognosticators--heart rate (mean, 84.4 beats per minute), plasma renin activity (mean, 15.4 ng per milliliter per hour), plasma norepinephrine (mean, 700 pg per milliliter), serum sodium (mean, 135.7 mmol per liter), and stroke-work index (mean, 21.0 g-meters per square meter)--found only plasma norepinephrine to be independently (P = 0.002) related to the subsequent risk of mortality. Norepinephrine was also higher in patients who died from progressive heart failure than in those who died suddenly. These data suggest that a single resting venous blood sample showing the plasma norepinephrine concentration provides a better guide to prognosis than other commonly measured indexes of cardiac performance.

Integrity signals

Registry

Crossref · 10.1056/nejm198409273111303

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 925
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citation
Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man
Lake, C., Ziegler, M. G., & Kopin, I. J. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90210-1 · Cited by 548
Determinants of Survival in Patients with Ventricular Tachyarrhythmias
Swerdlow, C. D., Winkle, R. A., & Mason, J. W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082402 · Cited by 508
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Augmentation of the Plasma Nor-Epinephrine Response to Exercise in Patients with Congestive Heart Failure
Chidsey, C. A., Harrison, D. C., & D, E. B. M. (1962) · New England Journal of Medicine · doi:10.1056/nejm196209272671305 · Cited by 439

Show all 23 references

Research works printed but not linked: 2

Hopkins A. Survival analysis with covariates — Cox models. In: BMDP statistical software. Berkeley, Calif.: University of California Press, 1983: 576–94.
10.2307/2281868 · DOI · Paper page

Sorted by citations

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Self-citation
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
Self-citation
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Self-citation
PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)
Marx, S. O., Reiken, S. R., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N., & Marks, A. R. (2000) · Cell · doi:10.1016/s0092-8674(00)80847-8 · Cited by 1,981
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,715
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386
Self-citation
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
Troughton, R. W., FRAMPTON, C. M. A., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,358
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
Bristow, M. R., Ginsburg, R., Umans, V. A. W. M., Fowler, M. B., Minobe, W. A., Rasmussen, R., Zera, P. H., Menlove, R. L., Shah, P., & Jamieson, S. W. (1986) · Circulation Research · doi:10.1161/01.res.59.3.297 · Cited by 1,326
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Biomarkers in Heart Failure
D, E. B. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800239 · Cited by 1,252
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
Hormones and Hemodynamics in Heart Failure
Schrier, R. W., & Abraham, W. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410806 · Cited by 1,192
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation
Aaronson, K. D., Schwartz, J. S., Chen, T.-M., Wong, K.-L., Goin, J. E., & MANCINI, D. M. (1997) · Circulation · doi:10.1161/01.cir.95.12.2660 · Cited by 1,182
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
Swedberg, K. B., Eneroth, P. H. E., KJEKSHUS, J. K., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,147
Sympathovagal Balance: A Critical Appraisal
Eckberg, D. L. (1997) · Circulation · doi:10.1161/01.cir.96.9.3224 · Cited by 1,087
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
Hasking, G. J., Esler, M. D., Jennings, G. L., Burton, D., Johns, J. A., & Korner, P. I. (1986) · Circulation · doi:10.1161/01.cir.73.4.615 · Cited by 1,028
Cytokines and Cytokine Receptors in Advanced Heart Failure
Deswal, A. M., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.16.2055 · Cited by 1,014
A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
The Beta-Blocker Evaluation of Survival Trial Investigators (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442202 · Cited by 1,005
Inflammatory Mediators and the Failing Heart
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 987
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
Tsutamoto, T., Wada, A., Maeda, K., 久永, 智., Maeda, Y., 深井, 大., Ohnishi, M., Sugimoto, Y., & Kinoshita, M. (1997) · Circulation · doi:10.1161/01.cir.96.2.509 · Cited by 960
Seven-transmembrane-spanning receptors and heart function
Rockman, H. A., Koch, W. J., & Lefkowitz, R. J. (2002) · Nature · doi:10.1038/415206a · Cited by 937
Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients
La Rovere, M. T., Pinna, G. D., Maestri, R., Mortara, A., Capomolla, S., Febo, O., Ferrari, R., Franchini, M., Gnemmi, M., Opasich, C., et al. (2003) · Circulation · doi:10.1161/01.cir.0000047275.25795.17 · Cited by 917
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B. J., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 923
Pathophysiological Characterization of Isolated Diastolic Heart Failure in Comparison to Systolic Heart Failure
Kitzman, D. W. (2002) · JAMA · doi:10.1001/jama.288.17.2144 · Cited by 883
Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure
Jacobson, A. F., Senior, R., Cerqueira, M. D., Wong, N. D., Thomas, G. S., López, V. A., Agostini, D., Weiland, F., Chandna, H., & Narula, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.014 · Cited by 867
Adrenergic effects on the biology of the adult mammalian cardiocyte.
Mann, D. L., Kent, R. L., Parsons, B., & Cooper, G. (1992) · Circulation · doi:10.1161/01.cir.85.2.790 · Cited by 865
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
Anand, I. S., Fisher, L. D., Chiang, Y., Latini, R., Masson, S., Maggioni, A. P., Glazer, R. D., Tognoni, G., & Cohn, J. N. (2003) · Circulation · doi:10.1161/01.cir.0000054164.99881.00 · Cited by 857
Self-citation
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Fox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61171-x · Cited by 789
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
Maeda, K., Tsutamoto, T., Wada, A., 久永, 智., & Kinoshita, M. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70041-9 · Cited by 788
Lipolysis: cellular mechanisms for lipid mobilization from fat stores
Grabner, G. F., Xie, H., Schweiger, M., & Zechner, R. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00493-6 · Cited by 809
QT dispersion and sudden unexpected death in chronic heart failure
Barr, C. S., Naas, A. A. O., Freeman, M., Lang, C. C., & Struthers, A. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91164-9 · Cited by 767
Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy
Neubauer, S., Horn, M., Cramer, M., Harre, K., Newell, J. B., Peters, W., Pabst, T., Ertl, G., Hahn, D., Ingwall, J. S., et al. (1997) · Circulation · doi:10.1161/01.cir.96.7.2190 · Cited by 748
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
Pfeffer, M. A., Pfeffer, J. M., Steinberg, C., & Finn, P. V. (1985) · Circulation · doi:10.1161/01.cir.72.2.406 · Cited by 717
Neurohormonal activation in heart failure with reduced ejection fraction
Hartupee, J. C., & Mann, D. L. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.163 · Cited by 748
Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis
Saul, J. P., Arai, Y., Berger, R. D., Lilly, L. S., Colucci, W. S., & Cohen, R. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91172-1 · Cited by 706
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ōno, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 720
Sympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular Disease
Malpas, S. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00007.2009 · Cited by 696
Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure
Salvo, T. G. D., Mathier, M. M., Semigran, M. J., & Dec, G. W. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00511-n · Cited by 683
Adverse consequences of high sympathetic nervous activity in the failing human heart
Kaye, D. M., Lefkovits, J., Jennings, G. L., Bergin, P., Broughton, A., & Esler, M. D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00332-0 · Cited by 665
Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair
Tiburcy, M., Hudson, J. E., Balfanz, P., Schlick, S. F., Meyer, T., Liao, M.-L. C., Levent, E., Raad, F. S., Zeidler, S., Wingender, E., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024145 · Cited by 663
Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin
Richards, M., Nicholls, M. G., Yandle, T. G., Frampton, C. M., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R. E., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 628
Self-citation
The Autonomic Nervous System and Hypertension
Mancia, G., & Grassi, G. (2014) · Circulation Research · doi:10.1161/circresaha.114.302524 · Cited by 627
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
Frantz, S., Hundertmark, M., Schulz‐Menger, J., Bengel, F. M., & Bauersachs, J. K. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac223 · Cited by 653
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association
Chow, S. L., Maisel, A. S., Anand, I. S., Bozkurt, B., de Boer, R. A., Felker, G. M., Fonarow, G. C., Greenberg, B., Januzzi, J. L., Kiernan, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000490 · Cited by 626
The Autonomic Nervous System and Heart Failure
Florea, V. G., & Cohn, J. N. (2014) · Circulation Research · doi:10.1161/circresaha.114.302589 · Cited by 587
Self-citation
Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.
Tsutamoto, T., Hisanaga, T., Wada, A., Maeda, K., Ohnishi, M., Fukai, D., Mabuchi, N., Sawaki, M., & Kinoshita, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00494-4 · Cited by 560
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
Keith, M. E., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A., & Jeejeebhoy, K. N. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00101-6 · Cited by 560
Sympathetic Nervous System Activation in Human Heart Failure
Floras, J. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.061 · Cited by 561
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
Lee, W. H., & Packer, M. (1986) · Circulation · doi:10.1161/01.cir.73.2.257 · Cited by 561
The human sympathetic nervous system: its relevance in hypertension and heart failure
Parati, G., & Esler, M. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs041 · Cited by 538
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease
Zoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
Hein, L., Altman, J. D., & Kobilka, B. K. (1999) · Nature · doi:10.1038/46040 · Cited by 518
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
O’Connor, C. M., Gattis, W. A., Uretsky, B. F., Adams, K. F., McNulty, S. E., Grossman, S. H., McKenna, W. J., Zannad, F. M., Swedberg, K. B., Gheorghiade, M., et al. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70250-4 · Cited by 516
How to measure baroreflex sensitivity
Parati, G., Rienzo, M. D., & Mancia, G. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018010-00003 · Cited by 515
Biomarkers for the diagnosis and management of heart failure
Castiglione, V., Aimo, A., Vergaro, G., Saccaro, L. F., Passino, C., & Emdin, M. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10105-w · Cited by 535
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 533
Depressed Heart Rate Variability as an Independent Predictor of Death in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy
Ponikowski, P. P., Anker, S. D., Chua, T. P., Szełemej, R., Piepoli, M. F., Adamopoulos, S. N., Webb-Peploe, K., Harrington, D., Banasiak, W., Wrabec, K., et al. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00215-4 · Cited by 497
Rat models of hypertension, cardiac hypertrophy and failure
Doggrell, S. A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00076-5 · Cited by 497
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.
Feldman, M. D., Copelas, L., Gwathmey, J. K., Phillips, P. J., Warren, S. E., Schöen, F. J., Grossman, W., & Morgan, J. P. (1987) · Circulation · doi:10.1161/01.cir.75.2.331 · Cited by 486
Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
Mente, A., O'Donnell, M., Rangarajan, S., Dagenais, G., Lear, S., McQueen, M., Diaz, R., Avezum, A., Lopez-Jaramillo, P., Lanas, F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30467-6 · Cited by 483
Effects of Nasal CPAP on Sympathetic Activity in Patients With Heart Failure and Central Sleep Apnea
Naughton, M. T., Benard, D., Liu, P. P., Rutherford, R., Rankin, F., & Bradley, T. D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633695 · Cited by 474
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human
Haghighi, K., Kolokathis, F., Pater, L., Lynch, R. A., Asahi, M., Gramolini, A. O., Fan, G.-C., Tsiapras, D., Hahn, H. S., Adamopoulos, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17892 · Cited by 478
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
Zhu, W., Zheng, M., Koch, W. J., Lefkowitz, R. J., Kobilka, B. K., & Xiao, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1607 · Cited by 473
How to assess sympathetic activity in humans
Grassi, G., & Esler, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917060-00001 · Cited by 455
Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
Likoff, M. J., Chandler, S. L., & Kay, H. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91183-0 · Cited by 453
Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.
Huffman, J. C., Celano, C. M., Beach, S. R., Motiwala, S. R., & Januzzi, J. L. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/695925 · Cited by 445
Selection and Treatment of Candidates for Heart Transplantation
Costanzo, M. R., Augustine, S., Bourge, R. C., Bristow, M. R., OʼConnell, J. B., Driscoll, D., & Rose, E. A. (1995) · Circulation · doi:10.1161/01.cir.92.12.3593 · Cited by 437
Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
Engelmeier, R. S., O’Connell, J. B., Walsh, R. A., Rad, N., Scanlon, P. J., & Gunnar, R. M. (1985) · Circulation · doi:10.1161/01.cir.72.3.536 · Cited by 438
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
Richards, M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J. M., FRAMPTON, C. M. A., Turner, J. G., Crozier, I., & Yandle, T. G. (2003) · Circulation · doi:10.1161/01.cir.0000070953.76250.b9 · Cited by 433
Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart Failure
Grassi, G. M., Seravalle, G., Cattaneo, B. M., Lanfranchi, A. K., Vailati, S., Giannattasio, C., Bo, A. D., Sala, C., Bolla, G. B., Pozzi, M., et al. (1995) · Circulation · doi:10.1161/01.cir.92.11.3206 · Cited by 431
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
Kazanegra, R., Cheng, V. L., Garcia, A., Krishnaswamy, P., Gardetto, N. J., Clopton, P., & Maisel, A. S. (2001) · Journal of Cardiac Failure · doi:10.1054/jcaf.2001.23355 · Cited by 420
Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure
Xie, G., Berk, M. R., Smith, M. D., Gurley, J. C., & DeMaria, A. N. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90553-3 · Cited by 425
Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.
Heilbrunn, S., Shah, P., Bristow, M. R., Valantine, H. A., Ginsburg, R., & Fowler, M. B. (1989) · Circulation · doi:10.1161/01.cir.79.3.483 · Cited by 425
Evidence of a Selective Increase in Cardiac Sympathetic Activity in Patients with Sustained Ventricular Arrhythmias
Meredith, I. T., Broughton, A., Jennings, G. L., & Esler, M. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108293250905 · Cited by 420
Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease
Bolger, A., Sharma, R., Li, W., Leenarts, M., Kalra, P., Kemp, M., Coats, A., Anker, S., & Gatzoulis, M. (2002) · Circulation · doi:10.1161/01.cir.0000020009.30736.3f · Cited by 424
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
Maeda, K., Tsutamoto, T., Wada, A., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00912-8 · Cited by 417
Tackling heart failure in the twenty-first century
Mudd, J. O., & Kass, D. A. (2008) · Nature · doi:10.1038/nature06798 · Cited by 417
Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure
Ligtenberg, G., Blankestijn, P. J., Oey, P. L., Klein, I. H. H. T., Dijkhorst-Oei, L.-T., Boomsma, F., Wieneke, G. H., van Huffelen, A. C., & Koomans, H. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401704 · Cited by 407
Role of Diminished Renal Function in Cardiovascular Mortality
Schrier, R. W. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.067 · Cited by 402
Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction.
Omland, T. M., Lie, R. T., Aakvaag, A., Aarsland, T., & Dickstein, K. (1994) · Circulation · doi:10.1161/01.cir.89.4.1573 · Cited by 401
Predictors of total mortality and sudden death in mild to moderate heart failure
Gradman, A. H., DEEDWANIA, P. C., Cody, R. J., Massie, B. M., Packer, M., Pitt, B., & Goldstein, S. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90093-4 · Cited by 394
Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance
Ponikowski, P. P., Francis, D. P., Piepoli, M. F., Davies, C., Chua, T. P., Davos, C. H., Florea, V. G., Banasiak, W., Poole-Wilson, P. A., Coats, A. J. S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.7.967 · Cited by 398
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
Richards, M., Doughty, R. N., Nicholls, M. G., MacMahon, S. W., Sharpe, N., Murphy, J., Espiner, E. A., FRAMPTON, C. M. A., & Yandle, T. G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01269-4 · Cited by 389
Autonomic Nervous System and Immune System Interactions
Kenney, M., & Ganta, C. K. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130051 · Cited by 441
Adverse Mortality Effect of Central Sympathetic Inhibition with Sustained-Release Moxonidine in Patients with Heart Failure (MOXCON)
Cohn, J. N., Pfeffer, M. A., Rouleau, J. L., Sharpe, N., Swedberg, K. B., Straub, M., Wiltse, C. G., Wright, T. J., & for the MOXCON Investigators (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00163-6 · Cited by 382
Self-citation
Absence of Low-Frequency Variability of Sympathetic Nerve Activity in Severe Heart Failure
van de Borne, P., Montano, N., Pagani, M., Oren, R. M., & Somers, V. K. (1997) · Circulation · doi:10.1161/01.cir.95.6.1449 · Cited by 376
Cardiac Cachexia
Anker, S. D., & Coats, A. J. S. (1999) · CHEST Journal · doi:10.1378/chest.115.3.836 · Cited by 377
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
Maisel, A. S., Koon, J., Krishnaswamy, P., Kazenegra, R., Clopton, P., Gardetto, N. J., Morrisey, R., Garcia, A., Chiu, A., & DeMaria, A. N. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113215 · Cited by 377
Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model
Zhang, Y., Popović, Z., Bibevski, S., Fakhry, I., Sica, D. A., Wagoner, D. R. V., & Mazgalev, T. N. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.873968 · Cited by 377
Modulation of the Ryanodine Receptor and Intracellular Calcium
Zalk, R., Lehnart, S. E., & Marks, A. R. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.053105.094237 · Cited by 371
The Short-term Effects of Digoxin in Patients With Right Ventricular Dysfunction From Pulmonary Hypertension
Rich, S., Seidlitz, M., Dodin, E., Osimani, D., Judd, D., Genthner, D., McLaughlin, V. V., & Francis, G. S. (1998) · CHEST Journal · doi:10.1378/chest.114.3.787 · Cited by 370
Self-citation
Basic Mechanisms in Congestive Heart Failure
Mann, D. L., & Young, J. B. (1994) · CHEST Journal · doi:10.1378/chest.105.3.897 · Cited by 365
Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure
Floras, J. S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90466-e · Cited by 360
BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases
Silver, M. A., Maisel, A. S., Yancy, C. W., McCullough, P. A., Burnett, J. C. J., Francis, G. S., Mehra, M. R., Peacock, W. F., Fonarow, G. C., Gibler, W. B., et al. (2004) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2004.03271.x · Cited by 361
Self-citation
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials
KJEKSHUS, J. K. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90888-x · Cited by 357

Authors: Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T.
Affiliations: University of Minnesota (US)
ORCID: Cohn, Jay N.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1984-09-27
Volume: 311
Issue: 13
Pages: 819-823
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm198409273111303
OpenAlex: W2338638760
Cited by: 3,125
References: 23
Citations by year: 2026: 22 · 2025: 30 · 2024: 22 · 2023: 44 · 2022: 50 · 2021: 49 · 2020: 54 · 2019: 58 · 2018: 42 · 2017: 57 · 2016: 75 · 2015: 73 · 2014: 101 · 2013: 87 · 2012: 88
FWCI: 34.36
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords: plasma norepinephrine, congestive heart failure, prognosis, mortality risk, plasma renin activity, hemodynamics, sudden death, progressive heart failure, prognostic factors, heart rate, stroke work index, serum sodium
MeSH terms: Age Factors, Blood Pressure, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hemodynamics, Humans, Male, Middle Aged, Norepinephrine, Prognosis, Pulmonary Wedge Pressure, Renin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks